{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:54:26Z","timestamp":1777600466459,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,6]]},"DOI":"10.7759\/cureus.23902","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T06:42:29Z","timestamp":1649313749000},"source":"Crossref","is-referenced-by-count":2,"title":["Septic and Crystal-Induced Arthritis (Pseudogout) Post-COVID-19 Vaccination"],"prefix":"10.7759","author":[{"given":"Felix W","family":"Wireko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabah","family":"Khalafalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siham","family":"Mahgoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai CC","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020, 55:105924. 10.1016\/j.ijantimicag.2020.105924","journal-title":"Int J Antimicrob Agents"},{"key":"ref2","unstructured":"WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. (2020). Accessed. April 1, 2022: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-...."},{"key":"ref3","unstructured":"Centers for Disease Control and Prevention. How to protect yourself & others. (2022). Accessed. April 1, 2022: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/prevention.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic","volume":"10","author":"Riad A","year":"2021","unstructured":"Riad A, Pokorn\u00e1 A, Attia S, Klugarov\u00e1 J, Ko\u0161\u010d\u00edk M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021, 10:1428. 10.3390\/jcm10071428","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein NP","year":"2021","unstructured":"Klein NP, Lewis N, Goddard K, et al.. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. 2021, 326:1390-9. 10.1001\/jama.2021.15072","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108256","article-title":"Arthritis following COVID-19 vaccination: report of two cases","volume":"101","author":"Unal Enginar A","year":"2021","unstructured":"Unal Enginar A. Arthritis following COVID-19 vaccination: report of two cases. Int Immunopharmacol. 2021, 101:108256. 10.1016\/j.intimp.2021.108256","journal-title":"Int Immunopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.CC.21.00090","article-title":"Septic arthritis of the shoulder after SARS-CoV-2 Pfizer vaccination: a case report","volume":"11","author":"Massel DH","year":"2021","unstructured":"Massel DH, Haziza S, Rivera S, Mohile N, Subhawong TK, Hernandez VH. Septic arthritis of the shoulder after SARS-CoV-2 Pfizer vaccination: a case report. JBJS Case Connect. 2021, 11:10.2106\/JBJS.CC.21.00090","journal-title":"JBJS Case Connect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad A","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, et al.. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021, 9:435. 10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215724","article-title":"Risk of gout flares after vaccination: a prospective case cross-over study","volume":"78","author":"Yokose C","year":"2019","unstructured":"Yokose C, McCormick N, Chen C, et al.. Risk of gout flares after vaccination: a prospective case cross-over study. Ann Rheum Dis. 2019, 78:1601-4. 10.1136\/annrheumdis-2019-215724","journal-title":"Ann Rheum Dis"},{"key":"ref10","unstructured":"Centers for Disease Control and Prevention. Pfizer-BioNTech COVID-19 vaccine (also known as COMIRNATY). overview and safety. (2022). Accessed: April 1, 2022: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/Pfizer-BioNTech.html."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217914","article-title":"Case series of acute arthritis during COVID-19 admission","author":"L\u00f3pez-Gonz\u00e1lez MD","year":"2020","unstructured":"L\u00f3pez-Gonz\u00e1lez MD, Peral-Garrido ML, Calabuig I, et al.. Case series of acute arthritis during COVID-19 admission. Ann Rheum Dis. 2020, 10.1136\/annrheumdis-2020-217914","journal-title":"Ann Rheum Dis"},{"key":"ref12","article-title":"Approach to septic arthritis","volume":"84","author":"Horowitz DL","year":"2011","unstructured":"Horowitz DL, Katzap E, Horowitz S, Barilla-LaBarca ML. Approach to septic arthritis. Am Fam Physician. 2011, 84:653-60.","journal-title":"Am Fam Physician"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/93240-septic-and-crystal-induced-arthritis-pseudogout-post-covid-19-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:49Z","timestamp":1707507889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/93240-septic-and-crystal-induced-arthritis-pseudogout-post-covid-19-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.23902","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,6]]}}}